LBRXLB Pharmaceuticals Inc
What is the market doing?
Rangebound. That is the only one of 3 checks this filer's data supports, so take it as a single data point rather than a settled answer.
Choppy, but holding above its 200-day average. Oversold (RSI 20). Price is +11% vs its 200-day average.
Where this answer is blind. Insider selling is often routine (taxes, diversification); only cluster buying is a strong tell.
How LBRX is trading
LB Pharmaceuticals Inc is +116% over the past year while the S&P 500 is +18%: 98 points ahead of the market.
1-year return · S&P 500 +18%
- vs 200-day average
- +11%
vs 200-day average · a clear uptrend
- RSI (14)
- 20
RSI (14) · oversold, sold harder than it has been bought
- Below its 52-week high
- 30%
Below its 52-week high
Details›
- Last close2026-10-08
- $34.62
- 1 monthS&P 500 +1.6%
- −27%
- 1 yearS&P 500 +18%
- +116%
- vs 50-day average$43.74
- −21%
- 52-week high
- $49.48
- 52-week low
- $14.61
- Annualised volatility
- 62%
End-of-day closes from IEX; the S&P 500 comparison uses SPY over the same window. Prices are a reference point, not a basis for trading decisions.
Biotechnology
The closest names by size in the same industry